ATA341687A - Lyophilisierte oder ausgefaellte cephalosporinzusammensetzung aus zwitterion und salz - Google Patents

Lyophilisierte oder ausgefaellte cephalosporinzusammensetzung aus zwitterion und salz

Info

Publication number
ATA341687A
ATA341687A AT0341687A AT341687A ATA341687A AT A341687 A ATA341687 A AT A341687A AT 0341687 A AT0341687 A AT 0341687A AT 341687 A AT341687 A AT 341687A AT A341687 A ATA341687 A AT A341687A
Authority
AT
Austria
Prior art keywords
cephalosporine
zwitterion
fabulous
lyophilized
salt
Prior art date
Application number
AT0341687A
Other languages
English (en)
Other versions
AT388672B (de
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ATA341687A publication Critical patent/ATA341687A/de
Application granted granted Critical
Publication of AT388672B publication Critical patent/AT388672B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
AT0341687A 1987-01-09 1987-12-23 Lyophilisierte oder ausgefaellte cephalosporinzusammensetzung aus zwitterion und salz AT388672B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/001,945 US4808617A (en) 1985-12-18 1987-01-09 Lyophilized or precipitated cephalosporin zwitterion and salt combination

Publications (2)

Publication Number Publication Date
ATA341687A true ATA341687A (de) 1989-01-15
AT388672B AT388672B (de) 1989-08-10

Family

ID=21698538

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0341687A AT388672B (de) 1987-01-09 1987-12-23 Lyophilisierte oder ausgefaellte cephalosporinzusammensetzung aus zwitterion und salz

Country Status (33)

Country Link
US (1) US4808617A (de)
JP (1) JP2568226B2 (de)
KR (1) KR950010154B1 (de)
AR (1) AR243501A1 (de)
AT (1) AT388672B (de)
AU (1) AU606361B2 (de)
BE (1) BE1002114A3 (de)
CA (1) CA1307464C (de)
CH (1) CH676202A5 (de)
CS (1) CS265249B2 (de)
CY (1) CY1679A (de)
DD (1) DD264614A5 (de)
DE (1) DE3740588C2 (de)
DK (1) DK166404B1 (de)
ES (1) ES2008951A6 (de)
FI (1) FI89006C (de)
FR (1) FR2609396B1 (de)
GB (1) GB2199746B (de)
GR (1) GR871860B (de)
HK (1) HK5593A (de)
HU (1) HU199686B (de)
IE (1) IE61238B1 (de)
IL (1) IL84346A (de)
IT (1) IT1215666B (de)
LU (1) LU87102A1 (de)
NL (1) NL193266C (de)
OA (1) OA08796A (de)
PT (1) PT86157B (de)
SE (1) SE467910B (de)
SG (1) SG114792G (de)
SU (1) SU1575942A3 (de)
YU (1) YU46689B (de)
ZA (1) ZA88114B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
WO2005094800A2 (en) * 2004-03-31 2005-10-13 Lupin Ltd. A co-precipitated cefepime composition and process for preparation thereof
WO2006109324A2 (en) * 2005-04-13 2006-10-19 Lupin Limited Processes for preparation of amorphous cefepime acid addition salts
JP5491119B2 (ja) * 2009-10-02 2014-05-14 日東電工株式会社 薬物含有微粒子を含む医薬組成物およびその製造方法
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
CA2906151A1 (en) 2013-03-15 2014-09-18 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
JP6218204B2 (ja) 2014-09-04 2017-10-25 塩野義製薬株式会社 カテコール基を有するセファロスポリン類を含有する製剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953439A (en) * 1973-08-01 1976-04-27 Smithkline Corporation Substituted phenylglycylcephalosporins
US4029655A (en) * 1975-04-11 1977-06-14 Eli Lilly And Company Method of preparing stable sterile crystalline cephalosporins for parenteral administration
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
US4604386A (en) * 1984-07-09 1986-08-05 Eli Lilly And Company 3-(alkynylalkyloxy) cephalosporins
JPS61130223A (ja) * 1984-11-28 1986-06-18 Shionogi & Co Ltd 抗菌性凍結乾燥製剤
CA1284994C (en) * 1985-08-05 1991-06-18 Murray Arthur Kaplan Cephalosporin salts and injectable compositions

Also Published As

Publication number Publication date
GB2199746B (en) 1990-10-24
NL193266B (nl) 1999-01-04
GR871860B (en) 1988-05-10
DK166404B1 (da) 1993-05-17
CA1307464C (en) 1992-09-15
AU606361B2 (en) 1991-02-07
SE467910B (sv) 1992-10-05
NL8800025A (nl) 1988-08-01
SE8800036L (sv) 1988-07-10
CY1679A (en) 1993-10-10
FR2609396A1 (fr) 1988-07-15
NL193266C (nl) 1999-05-06
OA08796A (fr) 1989-03-31
FI875122A (fi) 1988-07-10
US4808617A (en) 1989-02-28
BE1002114A3 (fr) 1990-07-10
HU199686B (en) 1990-03-28
IL84346A (en) 1992-05-25
SG114792G (en) 1992-12-24
HK5593A (en) 1993-02-05
DK577387A (da) 1988-07-10
PT86157A (en) 1987-12-01
HUT46223A (en) 1988-10-28
IT1215666B (it) 1990-02-22
FI89006C (fi) 1993-08-10
JP2568226B2 (ja) 1996-12-25
AU8085687A (en) 1989-05-11
JPS63208522A (ja) 1988-08-30
FR2609396B1 (fr) 1993-01-29
GB2199746A (en) 1988-07-20
SE8800036D0 (sv) 1988-01-08
GB8725875D0 (en) 1987-12-09
CS15888A2 (en) 1989-01-12
DE3740588C2 (de) 1996-07-11
DE3740588A1 (de) 1988-07-21
KR880008811A (ko) 1988-09-13
AR243501A1 (es) 1993-08-31
CH676202A5 (de) 1990-12-28
SU1575942A3 (ru) 1990-06-30
DD264614A5 (de) 1989-02-08
PT86157B (pt) 1991-02-08
CS265249B2 (en) 1989-10-13
IE872970L (en) 1988-07-09
IL84346A0 (en) 1988-04-29
ZA88114B (de) 1988-06-27
FI89006B (fi) 1993-04-30
LU87102A1 (fr) 1988-08-23
KR950010154B1 (ko) 1995-09-11
IE61238B1 (en) 1994-10-19
AT388672B (de) 1989-08-10
FI875122A0 (fi) 1987-11-19
YU2388A (en) 1989-10-31
ES2008951A6 (es) 1989-08-16
DK577387D0 (da) 1987-11-03
YU46689B (sh) 1994-04-05
IT8819013A0 (it) 1988-01-07

Similar Documents

Publication Publication Date Title
DE10075008I1 (de) Analoga von Insulin und deren Herstellungsmethode
TR25949A (tr) Kefeke olusmasini önleyici oral bilesik
DK273888D0 (da) Salterstatning og krydderier med et indhold deraf
DK194488A (da) Fastgoerelse i underlag med hulrum
DK183288A (da) Nedgangsvejbroend med t-formet haengsel
IT1200950B (it) Unghia finta o artificiale ad applicazione perfezionata all'unghia naturale
AT388672B (de) Lyophilisierte oder ausgefaellte cephalosporinzusammensetzung aus zwitterion und salz
AT399878B (de) Kristallines cephalosporinsalz und dieses enthaltendes pharmazeutisches mittel
ATE73800T1 (de) Anhydrisches und kristallines natriumsalz von 5- chloro-3-(2-thenoyl)-2-oxindol-1-carboxamid.
ATA280786A (de) Ventiliertes zigarettenfilter und filterzigarette
DK508084A (da) Modificerede glucosaminoglucaner med antithrombotisk aktivitet
PT84395A (de) Rollstein und aus rollsteine zusammengesetzte rollbahn
IT1177580B (it) Composizione farmaceutica contenente rifampicina e procedimento per prepararla
IT8619032A0 (it) Perfezionamenti apportati al trattamento di materiali in particelle.
KR870700284A (ko) 어망현가장치
IT8667408A0 (it) Preparati farmaceutici ad effetto antiipertensivo e cardioprotettivo
IT1191639B (it) Composizione farmaceutica contenente fosfocreatina e metodo per preparla
DK201884D0 (da) Farmaceutisk praeparat med anti-hypertensiv virkning
DK36191A (da) Farmaceutisk komposition indeholdende den antibiotiske forbindelse cl-1957a eller et farmaceutisk acceptabelt salt deraf sammen med en farmaceutisk acceptabel baerer
RO96327A (ro) Compozitie nematocida si insecticida
IT8421890A1 (it) 3-idrazinopropionati sostituiti ad attivita' antiaritmica
DK464086A (da) Forbindelser med pesticid virkning
IT8547704A1 (it) Diazepinoindoli loro preparazione e loro impiego come medicamenti
KR900007857A (ko) 1,4,2-옥사자포스폴리딘-4-아세트산, 2-알콕시-2-옥사이드의 아민염
DK70984D0 (da) Nitromethylenderivater med pesticid virkning

Legal Events

Date Code Title Description
ELA Expired due to lapse of time